India Bioresorbable Polymers Market Size is Growing at CAGR 17.0% by 2032

India’s bioresorbable polymers market is undergoing a structural transformation, accelerating away from permanent metallic implants toward absorbable sutures, orthopedic fixation devices, drug delivery matrices, and vascular scaffolds across hospital, medical device, and pharmaceutical channels, supported by rising surgical volumes, the medical devices PLI scheme, and growing clinical preference for implants that need no removal surgery.

According to Market Research Outlook’s latest research report, the “India Bioresorbable Polymers Market“ is expected to grow from USD 34 million in 2025 to USD 102 million by 2032, at a CAGR of 17.0%, supported by rising orthopedic and cardiovascular procedure volumes, expanding domestic medical device manufacturing under the PLI scheme, growing PLGA-based controlled release drug delivery research, and India’s widening absorbable suture export base.

India’s bioresorbable polymers market is moving into a new phase of growth, with demand shifting away from imported finished implants toward domestically manufactured absorbable devices built on imported medical grade resin, alongside rising pharmaceutical use of PLGA microspheres for depot injectable formulations.

What is changing is not just the scale, but the nature of demand. Medical device manufacturers, pharmaceutical formulators, hospitals, and research institutes are increasingly treating these materials as a specification-led clinical input tied to degradation profile, molecular weight, and biocompatibility, rather than a commodity resin purchased on price alone.

This shift is being reinforced by expanding medical device manufacturing clusters across Gujarat, Maharashtra, Karnataka, and Tamil Nadu, the rollout of four approved medical device parks, rising Ayushman Bharat procedure coverage, and growing regulatory clarity under the CDSCO Medical Device Rules. As a result, bioresorbable polymers are increasingly positioned as a strategic clinical material, tailored to specific device and therapy segments rather than a uniform resin offering.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “India Bioresorbable Polymers Market.”

The growth of the India bioresorbable polymers market is closely linked to rising absorbable device manufacturing, with Indian consumption of medical grade resin reaching 30 metric tonnes in 2025 against 16 metric tonnes in 2021. Global resin suppliers including Evonik Industries, Corbion, Mitsui Chemicals, Poly-Med, and Ashland serve Indian demand through authorised distributors, while domestic device makers such as Healthium Medtech, Meril Life Sciences, and Sahajanand Medical Technologies scale absorbable suture, orthopedic fixation, and vascular scaffold output across metro and industrial clusters.

At the same time, hospitals and surgical centres across Maharashtra, Gujarat, Karnataka, Tamil Nadu, Telangana, and Delhi NCR are raising adoption of absorbable implants, supported by Ayushman Bharat procedure coverage, Production Linked Incentive allocations of INR 3,420 crore for medical devices, and the Promotion of Medical Device Parks scheme, creating steady upstream demand for PLA, PLGA, PGA, and PCL grades across the India bioresorbable polymers market.

Product development is increasingly focused on higher-specification bioresorbable grades, including PLGA copolymers with tunable degradation windows between 6 and 24 months, high-purity PLLA for load-bearing orthopedic fixation, PLA-PEG copolymers for implantable devices, oriented tubing for vascular scaffolds, and microsphere-grade resin for depot injectables. As a result, demand is gradually shifting toward multifunctional grades offering strength retention, predictable resorption, and biocompatibility together, supporting higher value realisation in implant and drug delivery segments.

Despite this strong momentum, the India bioresorbable polymers market continues to face challenges. Import dependence at 96% of medical grade resin requirement, high landed material cost, moisture sensitivity and cold chain storage needs, and lengthy CDSCO approval timelines remain key concerns. Limited domestic polymerisation and purification capability adds further complexity. However, PLI-backed capacity creation, growing contract manufacturing depth, and rising investment in domestic lactide and glycolide chemistry are gradually easing these pressures over time.

Looking ahead, opportunities are emerging across domestic medical grade PLA and PLGA polymerisation, absorbable suture and orthopedic fixation exports, 3D printed tissue engineering scaffolds, and growing regenerative medicine research in metro academic centres. Increasing collaboration between global resin producers, Indian device manufacturers, pharmaceutical formulators, and contract manufacturing organisations is also accelerating product innovation, regulatory readiness, and clinical reach, positioning the market for sustained, value-driven, and innovation-led growth through 2032.

Major companies operating in India Bioresorbable Polymers Market are:

• Evonik Industries AG (RESOMER)
• Corbion N.V. (Purasorb)
• Ashland Inc.
• Mitsui Chemicals Inc.
• Poly-Med Inc.
• Foster Corporation
• Zeus Company Inc.
• Merck KGaA
• KLS Martin Group
• Bezwada Biomedical LLC
• Healthium Medtech Limited
• Meril Life Sciences Pvt. Ltd.
• Sahajanand Medical Technologies Limited

Download Free Sample Report

The India bioresorbable polymers market is entering a structural upcycle where security of medical grade resin supply, technical leadership in PLGA and PLLA grades, and the ability to serve diverse customers across device, pharmaceutical, and hospital channels will increasingly separate long-term leaders from the rest. As domestic device manufacturing deepens and absorbable implants displace permanent metallic fixation, demand is shifting toward higher-specification, regulatory-ready, and clinically validated grades, noted a senior analyst at Market Research Outlook.

India Bioresorbable Polymers Market, provides a detailed assessment of the India bioresorbable polymers market, covering market size, structure, and long-term growth dynamics. It includes comprehensive segmentation across polymer types, applications, forms, sales channels, end-use industries, and regional markets, along with analysis of key trends, growth drivers, challenges, and emerging opportunities shaping the bioresorbable polymers market in India.

Don’t Miss the Business Opportunity in the India Bioresorbable Polymers Market

Consult our analysts to gain critical insights and accelerate your business growth. The report’s in-depth analysis provides comprehensive information on growth potential, emerging trends, and key market statistics. It also highlights the factors influencing future market size and delivers insights into product innovation, industry demand drivers, regulatory framework, growth opportunities, challenges, and competitive dynamics to support informed strategic decision-making across the India bioresorbable polymers market.

About Us

Market Research Outlook delivers market intelligence and data-driven insights across healthcare, medical devices, specialty polymers, and life sciences markets.

Contact Us:

Market Research Outlook

Phone: +91-9457319032

Email: Sarita@marketresearchoutlook.com